Neurodevelopmental outcome of newborns with persistent pulmonary hypertension

Malaysian Journal of Medical Sciences

Volumn 18, Issue 4, 2011, Pages 57-61

  Rohana, Jaafar ^a   Boo, Nem Yun ^b   Chandran, Viji ^a   Sarvananthan, Rajini ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^b UNIVERSITI TUNKU ABDUL RAHMAN   (Malaysia)

Author keywords

Developmental disabilities; Magnesium sulphate; Neurology; Nitric oxide; Persistent pulmonary hypertension of newborn

Indexed keywords

MAGNESIUM SULFATE; NITRIC OXIDE;

ARTICLE; BRAIN DEVELOPMENT; CLINICAL ARTICLE; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DRUG POTENTIATION; FEMALE; HUMAN; INFANT; LOADING DRUG DOSE; MALE; MENTAL DEVELOPMENT; MONOTHERAPY; NEUROLOGIC EXAMINATION; NEWBORN PERIOD; OUTCOME ASSESSMENT; PERSISTENT PULMONARY HYPERTENSION; PHYSICAL DEVELOPMENT; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SURVIVOR;

EID: 80053526509     PISSN: 1394195X     EISSN: 21804303     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Clark RH. High-frequency ventilation. J Pediatr. 1994;124 (5 Pt 1):661-670.
2. Kinsella JP, Truog WE, Walsh WE, Goldberg RN, Bancalari E, Mayock DE, et al. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr. 1997;131(1):55-62.
3. Abu-Osba YK, Galai O, Manasra K, Rejjal A. Treatment of severe persistent pulmonary hypertension of the newborn with magnesium sulphate. Arch Dis Child. 1992;67(1 Spec No):31-35.
4. Tolsa JF, Cotting J, Sekarsi N, Payot M, Micheli JL, Calame A. Magnesium sulphate as an alternative and safe treatment for severe persistent pulmonary hypertension of the newborn. Arch Dis Child Fetal Neonatal Ed. 1995;72(3):F184-187.
5. Galli S, Bickle Graz M, Forcada-Guex M, Muehlethaler V, Jaunin L, Tolsa JF. Neuro-developmental follow-up of neonates treated with magnesium sulphate for persistent pulmonary hypertension. J Neonat Perinat Med. 2008;1(2):83-91.
6. Rosenberg AA, Kennaugh JM, Moreland SG, Fashaw LM, Hale KA, Torielli FM, et al. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. J Pediatr. 1997;131(1 Pt 1):70-75.
7. Lipkin PH, Davidson D, Spivak L, Straube R, Rhines J, Chang CT. Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with inhaled nitric oxide. J Pediatr. 2002;140(3):306-310.
8. Boo N Y, Rohana J, Yong SC, Bilkis AZ, Yong-Junina F. Inhaled nitric oxide and intravenous magnesium sulphate for the treatment of persistent pulmonary hypertension of the newborn. Singapore Med J. 2010;51(2):144-150.
9. Amiel-Tison C, Gosselin J. Neurological development from birth to six years: Guide to examination and evaluation. Baltimore (MD): The John Hopkins University Press; 2001.
10. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol. 1976;33(10):698-705.
11. Ichiba H, Matsunami S, Itoh F, Ueda T, Ohsasa Y, Yamano T. Three-year follow up of term and near term infants treated with inhaled nitric oxide. Pediatr Int. 2003;45(3):290-293.
12. Ellington M Jr, O'Reilly D, Allred EN, McCormick MC, Wessel DL, Kourembanas S. Child health status, neurodevelopmental outcome, and parental satisfaction in a randomized, controlled trial of nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics. 2001;107(6):1351-1356.
13. Berti A, Janes A, Furlan R, Macagno F. High prevalence of minor neurologic defcits in a long-term neurodevelopmental follow-up of children with severe persistent pulmonary hypertension of the newborn: A cohort study. Ital J Pediatr. 2010;36:45-51.